BioLife Solutions
BLFS
160 hedge funds and large institutions have $509M invested in BioLife Solutions in 2022 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 73 increasing their positions, 40 reducing their positions, and 25 closing their positions.
83% more repeat investments, than reductions
Existing positions increased: 73 | Existing positions reduced: 40
2.45% more ownership
Funds ownership: 84.44% → 86.89% (+2.5%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 25
2% less funds holding
Funds holding: 164 → 160 (-4)
36% less capital invested
Capital invested by funds: $797M → $509M (-$288M)
99% less call options, than puts
Call options by funds: $6K | Put options by funds: $524K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$17.3M |
| 2 |
Millennium Management
New York
|
+$7.14M |
| 3 |
PCM
Palisade Capital Management
Fort Lee,
New Jersey
|
+$5.41M |
| 4 |
State Street
Boston,
Massachusetts
|
+$3.86M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$3.21M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
-$20.1M |
| 2 |
RIM
Ranger Investment Management
Dallas,
Texas
|
-$14.3M |
| 3 |
N
Nuveen
Charlotte,
North Carolina
|
-$5.13M |
| 4 |
Russell Investments Group
London,
United Kingdom
|
-$3.4M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$3.06M |
BLFS Hedge Fund Activity: Q2 2022 in Review
160 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in BioLife Solutions (BLFS) for Q2 2022, worth a combined $509M — down 36% from $797M a quarter earlier.
Sellers outnumbered buyers: 25 funds closed out of BLFS and 24 opened new positions — a net loss of 1 holder — while 40 trimmed existing stakes and 73 added.
The largest buyer was BlackRock, adding an estimated $17.3M. The largest seller was Marshall Wace, exiting entirely with an estimated $20.1M sold.
- 160 institutional investors held BioLife Solutions (BLFS) as of Q2 2022, down from 164 in Q1 2022.
- Funds reported $509M of BioLife Solutions stock for Q2 2022, down 36% quarter-over-quarter.
- 24 funds opened new BioLife Solutions positions in Q2 2022 and 25 closed out, a net change of -1 holder.
- The largest BioLife Solutions buyer in Q2 2022 was BlackRock, an estimated $17.3M added.
- The largest BioLife Solutions seller in Q2 2022 was Marshall Wace, an estimated $20.1M sold.
Based on aggregated 13F filings for Q2 2022.